| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 902 | 185 | 1.653 | 7.490 | 6.274 | 6.562 | 6.590 | 6.587 | 4.298 |
| Total Income - EUR | 0 | 902 | 185 | 1.653 | 7.490 | 6.274 | 6.562 | 6.590 | 6.587 | 4.298 |
| Total Expenses - EUR | 1.384 | 608 | 301 | 825 | 494 | 1.436 | 2.105 | 552 | 3.775 | 341 |
| Gross Profit/Loss - EUR | -1.384 | 295 | -116 | 828 | 6.997 | 4.838 | 4.458 | 6.038 | 2.812 | 3.957 |
| Net Profit/Loss - EUR | -1.384 | 268 | -121 | 778 | 6.772 | 4.650 | 4.285 | 5.864 | 2.362 | 3.322 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Expres 09 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.503 | 2.317 | 2.045 | 1.799 | 1.559 | 1.759 | 1.352 | 1.435 | 1.159 | 874 |
| Current Assets | 4.734 | 5.153 | 5.268 | 5.172 | 5.325 | 9.817 | 11.113 | 16.839 | 19.873 | 23.017 |
| Inventories | 3.903 | 4.331 | 4.460 | 4.379 | 4.547 | 4.666 | 3.467 | 3.477 | 0 | 0 |
| Receivables | 831 | 822 | 808 | 793 | 778 | 763 | 746 | 699 | 15.859 | 15.715 |
| Cash | 0 | 0 | 0 | 0 | 0 | 4.388 | 6.900 | 12.663 | 4.014 | 7.303 |
| Shareholders Funds | -4.943 | -4.625 | -4.668 | -3.805 | 3.041 | 7.633 | 11.749 | 17.649 | 19.958 | 23.169 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.181 | 12.096 | 11.982 | 10.227 | 3.305 | 3.415 | 200 | 108 | 558 | 209 |
| Income in Advance | 0 | 0 | 0 | 549 | 538 | 528 | 516 | 518 | 516 | 513 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4612 - 4612" | |||||||||
| CAEN Financial Year |
4612
|
|||||||||
Comments - Bio Expres 09 Srl